DENTSPLY SIRONA Inc.
General ticker "XRAY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $2.7B (TTM average)
DENTSPLY SIRONA Inc. does not follow the US Stock Market performance with the rate: -13.9%.
Estimated limits based on current volatility of 1.8%: low 11.37$, high 11.77$
Factors to consider:
- Earnings expected soon, date: 2026-05-14 bmo
- Company pays dividends (irregularly): last record date 2025-12-26, amount 0.16$ (Y1.35%)
- Total employees count: 14000 (-6.7%) as of 2024
- Top business risk factors: Cybersecurity threats, Product development risks, Reimbursement risks, Goodwill impairment, Reputation and brand risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [6.91$, 14.75$]
- 2026-12-31 to 2027-12-31 estimated range: [7.98$, 16.16$]
Financial Metrics affecting the XRAY estimates:
- Positive: with PPE of 7.1 at the end of fiscal year the price was low
- Positive: -4.72 < Operating profit margin, % of 6.85
- Positive: 6.68 < Operating cash flow per share per price, % of 10.42
- Negative: Industry operating cash flow per share per price (median), % of 2.91 <= 5.46
- Positive: 19.49 < Shareholder equity ratio, % of 24.68 <= 42.60
- Negative: negative Net income
- Negative: Industry operating profit margin (median), % of -1.25 <= 3.02
- Negative: Investing cash flow per share per price, % of -5.85 <= -4.45
- Negative: Industry inventory ratio change (median), % of 0.78 > 0.31
- Negative: Industry earnings per price (median), % of 0 <= 0
Short-term XRAY quotes
Long-term XRAY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,965.00MM | $3,793.00MM | $3,680.00MM |
| Operating Expenses | $4,050.00MM | $4,672.00MM | $3,428.00MM |
| Operating Income | $-85.00MM | $-879.00MM | $252.00MM |
| Non-Operating Income | $-90.00MM | $-57.00MM | $-738.00MM |
| Interest Expense | $81.00MM | $69.00MM | $88.00MM |
| R&D Expense | $184.00MM | $165.00MM | $150.00MM |
| Income(Loss) | $-175.00MM | $-936.00MM | $-486.00MM |
| Taxes | $-43.00MM | $-26.00MM | $112.00MM |
| Profit(Loss)* | $-132.00MM | $-910.00MM | $-598.00MM |
| Stockholders Equity | $3,293.00MM | $1,942.00MM | $1,340.00MM |
| Inventory | $624.00MM | $564.00MM | $642.00MM |
| Assets | $7,370.00MM | $5,753.00MM | $5,429.00MM |
| Operating Cash Flow | $377.00MM | $461.00MM | $235.00MM |
| Capital expenditure | $149.00MM | $180.00MM | $131.00MM |
| Investing Cash Flow | $-89.00MM | $-197.00MM | $-132.00MM |
| Financing Cash Flow | $-307.00MM | $-302.00MM | $-80.00MM |
| Earnings Per Share** | $-0.62 | $-4.48 | $-3.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.